In vitro activity of riparin III in combination with antimicrobials against multidrug-resistant clinical isolates of Staphylococcus aureus and Acinetobacter baumannii

[1]  Tingting Guo,et al.  Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action , 2021, Frontiers in Pharmacology.

[2]  S. De-Simone,et al.  Acinetobacter baumannii Infections in Times of COVID-19 Pandemic , 2021, Pathogens.

[3]  S. Ding,et al.  Plant Natural Flavonoids Against Multidrug Resistant Pathogens , 2021, Advanced science.

[4]  G. Innes,et al.  Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[5]  S. Simionatto,et al.  Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings , 2020, Revista da Sociedade Brasileira de Medicina Tropical.

[6]  C. Cavalcanti,et al.  Ultrastructural changes caused by the combination of intravenous immunoglobulin with meropenem, amikacin and colistin in multidrug-resistant Acinetobacter baumannii. , 2020, Microbial pathogenesis.

[7]  F. Brayner,et al.  Antimicrobial activity and biofilm inhibition of riparins I, II and III and ultrastructural changes in multidrug-resistant bacteria of medical importance. , 2020, Microbial pathogenesis.

[8]  S. Bejarano,et al.  Antimicrobial profile of Acinetobacter baumannii at a tertiary hospital in Honduras: a cross-sectional analysis , 2020, Revista panamericana de salud publica = Pan American journal of public health.

[9]  I. Kassis,et al.  The epidemiology of Staphylococcus aureus bacteraemia in Israeli children: Community‐ vs hospital‐acquired or healthcare related infections , 2020, Acta paediatrica.

[10]  S. Beatson,et al.  Antimicrobial Resistance in ESKAPE Pathogens , 2020, Clinical Microbiology Reviews.

[11]  F. Brayner,et al.  In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates coharboring AMEs, blaNDM-1 and blaKPC-2. , 2020, Journal of global antimicrobial resistance.

[12]  K. Zahlane,et al.  The clinical and epidemiological risk factors of infections due to multi-drug resistant bacteria in an adult intensive care unit of University Hospital Center in Marrakesh-Morocco. , 2020, Journal of infection and public health.

[13]  Jong-seo Yoon,et al.  Nosocomial Acinetobacter baumannii infection in children in adult versus pediatric intensive care units , 2019, Pediatrics international : official journal of the Japan Pediatric Society.

[14]  M. Nikolich,et al.  Comparative genomic analysis of four multidrug resistant strains of Acinetobacter baumannii from the country of Georgia. , 2019, Journal of global antimicrobial resistance.

[15]  P. Wongsurakiat,et al.  Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection , 2019, BMC Pulmonary Medicine.

[16]  C. Tong,et al.  Clinical characteristics, risk factors, immune status and prognosis of secondary infection of sepsis: a retrospective observational study , 2019, BMC Anesthesiology.

[17]  Priscilla A DA Costa,et al.  Plant Extracts Display Synergism with Different Classes of Antibiotics. , 2019, Anais da Academia Brasileira de Ciencias.

[18]  B. Poinssot,et al.  Dual Mode of Action of Grape Cane Extracts against Botrytis cinerea. , 2019, Journal of agricultural and food chemistry.

[19]  N. Nayak,et al.  Burden of multidrug resistant respiratory pathogens in intensive care units of tertiary care hospital , 2019, Asian Journal of Medical Sciences.

[20]  M. Tyers,et al.  Drug combinations: a strategy to extend the life of antibiotics in the 21st century , 2019, Nature Reviews Microbiology.

[21]  M. Mann,et al.  Atividade antimicrobiana e antibiofilme do óleo essencial de folhas secas de Eucalyptus staigeriana , 2019 .

[22]  J. Parra-Ruiz,et al.  Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci. , 2019, Enfermedades infecciosas y microbiologia clinica.

[23]  Yangdong Wang,et al.  In vitro evaluation of antimicrobial combinations against imipenem-resistant Acinetobacter baumannii of different MICs. , 2018, Journal of infection and public health.

[24]  G. Rossolini,et al.  Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens , 2018, Front. Microbiol..

[25]  Prince Sharma,et al.  Curcumin alleviates persistence of Acinetobacter baumannii against colistin , 2018, Scientific Reports.

[26]  D. Barreca,et al.  The natural plant compound carvacrol as an antimicrobial and anti-biofilm agent: mechanisms, synergies and bio-inspired anti-infective materials , 2018, Biofouling.

[27]  D. Burgess,et al.  Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin , 2018, Antimicrobial Agents and Chemotherapy.

[28]  B. Erstad,et al.  Systematic Review and Meta-analysis of the Safety of Antistaphylococcal Penicillins Compared to Cefazolin , 2018, Antimicrobial Agents and Chemotherapy.

[29]  M. Karami,et al.  Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[30]  Xuming Deng,et al.  Pterostilbene, a Potential MCR-1 Inhibitor That Enhances the Efficacy of Polymyxin B , 2018, Antimicrobial Agents and Chemotherapy.

[31]  O. Stefanović,et al.  Synergistic Activity of Antibiotics and Bioactive Plant Extracts: A Study Against Gram-Positive and Gram-Negative Bacteria , 2017, Bacterial Pathogenesis and Antibacterial Control.

[32]  M. Correia,et al.  Effects of Caatinga Plant Extracts in Planktonic Growth and Biofilm Formation in Ralstonia solanacearum , 2018, Microbial Ecology.

[33]  W. Rui,et al.  In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae , 2018, The Journal of Antibiotics.

[34]  Gerard D. Wright.  Opportunities for natural products in 21st century antibiotic discovery. , 2017, Natural product reports.

[35]  R. Subramani,et al.  Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens , 2017, 3 Biotech.

[36]  I. C. Zampini,et al.  Antibacterial synergism of extracts from climbers belonging to Bignoniaceae family and commercial antibiotics against multi-resistant bacteria , 2017 .

[37]  W. Ko,et al.  Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity , 2017, Front. Microbiol..

[38]  M. Heimesaat,et al.  Finding Novel Antibiotic Substances from Medicinal Plants – Antimicrobial Properties of Nigella Sativa Directed against Multidrug-resistant Bacteria , 2017, European journal of microbiology & immunology.

[39]  A. Ghazali,et al.  Bactericidal Effect of Pterostilbene Alone and in Combination with Gentamicin against Human Pathogenic Bacteria , 2017, Molecules.

[40]  L. Sanhueza,et al.  Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli , 2017, PloS one.

[41]  N. Fam,et al.  Antimicrobial Efficacy of Doripenem Colistin Combination on Carbapenem-Resistant Acinetobacter baumanii Isolates by E-test Agar Dilution and Ultrastrastructural Methods , 2017 .

[42]  M. Raza,et al.  Ciprofloxacin-induced Hepatotoxicity in a Healthy Young Adult , 2017, Cureus.

[43]  H. Hosseinzadeh,et al.  Effect of Catechins, Green tea Extract and Methylxanthines in Combination with Gentamicin Against Staphylococcus aureus and Pseudomonas aeruginosa , 2016, Journal of pharmacopuncture.

[44]  Xiaofen Liu,et al.  Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model. , 2016, International journal of antimicrobial agents.

[45]  R. M. Freitas,et al.  In vitro antioxidant, antitumor and leishmanicidal activity of riparin A, an analog of the Amazon alkamides from Aniba riparia (Lauraceae) , 2016 .

[46]  Andrew J. Lamb,et al.  Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action , 2016, Cellular and Molecular Life Sciences.

[47]  D. van Duin,et al.  Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. , 2016, Infectious disease clinics of North America.

[48]  S. Jeong,et al.  In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii , 2015, Annals of laboratory medicine.

[49]  Tajelmolk Alaoui,et al.  Evaluation of antibacterial activity and synergistic effect between antibiotic and the essential oils of some medicinal plants , 2016 .

[50]  J. Li,et al.  Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria. , 2015, ACS infectious diseases.

[51]  F. Tuon,et al.  Combined therapy for multi-drug-resistant Acinetobacter baumannii infection--is there evidence outside the laboratory? , 2015, Journal of medical microbiology.

[52]  Serge Morand,et al.  Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria , 2014, Front. Microbiol..

[53]  V. Aleksić,et al.  Synergistic effect of Myrtus communis L. essential oils and conventional antibiotics against multi-drug resistant Acinetobacter baumannii wound isolates. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[54]  A. Méndez-Vilas.  Combination therapy : Synergism between natural plant extracts and antibiotics against infectious diseases , 2012 .

[55]  Timothy R. Walsh,et al.  Tackling antibiotic resistance , 2011, Nature Reviews Microbiology.

[56]  R. Nation,et al.  Colistin in the 21st century , 2009, Current opinion in infectious diseases.

[57]  M. Falagas,et al.  Polymyxin B: similarities to and differences from colistin (polymyxin E) , 2007, Expert review of anti-infective therapy.

[58]  M. Falagas,et al.  The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. , 2006, Journal of medical microbiology.

[59]  F. Odds,et al.  Synergy, antagonism, and what the chequerboard puts between them. , 2003, The Journal of antimicrobial chemotherapy.

[60]  F. Portaels,et al.  Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis , 2002, Antimicrobial Agents and Chemotherapy.

[61]  C. A. Marques.  IMPORTÂNCIA ECONÔMICA DA FAMÍLIA LAURACEAE Lindl. / ECONOMIC IMPORTANCE OF FAMILY LAURACEAE Lindl. , 2001 .

[62]  J. Pessoa,et al.  Preliminary Pharmacological Studies on three Benzoyl Amides, constituents of Aniba riparia (Nees) Mez (Lauraceae) , 2000 .

[63]  M. M. Cowan.  Plant Products as Antimicrobial Agents , 1999, Clinical Microbiology Reviews.

[64]  Russell E. Lewis,et al.  Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods , 1998, Antimicrobial Agents and Chemotherapy.

[65]  J. M. B. Filho,et al.  Avaliação da atividade antibiótica de extratos de lauraceae , 1988 .

[66]  Massayoshi Yoshida,et al.  Benzoyl esters and amides, styrylpyrones and neolignans from the fruits of Aniba riparia , 1987 .

[67]  R. Moellering.  Rationale for use of antimicrobial combinations. , 1983, The American journal of medicine.